Microbot Medical (MBOT) Competitors $4.05 +0.16 (+4.11%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$4.03 -0.02 (-0.62%) As of 09/12/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MBOT vs. BVS, AVNS, KIDS, ZIMV, TMCI, SMLR, CBLL, BFLY, DCTH, and RXSTShould you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include Bioventus (BVS), AVANOS MEDICAL (AVNS), OrthoPediatrics (KIDS), ZimVie (ZIMV), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), CeriBell (CBLL), Butterfly Network (BFLY), Delcath Systems (DCTH), and RxSight (RXST). These companies are all part of the "medical equipment" industry. Microbot Medical vs. Its Competitors Bioventus AVANOS MEDICAL OrthoPediatrics ZimVie Treace Medical Concepts Semler Scientific CeriBell Butterfly Network Delcath Systems RxSight Bioventus (NASDAQ:BVS) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends. Do insiders and institutionals believe in BVS or MBOT? 62.9% of Bioventus shares are owned by institutional investors. Comparatively, 16.3% of Microbot Medical shares are owned by institutional investors. 33.0% of Bioventus shares are owned by company insiders. Comparatively, 4.7% of Microbot Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is BVS or MBOT more profitable? Microbot Medical has a net margin of 0.00% compared to Bioventus' net margin of -0.03%. Bioventus' return on equity of 23.04% beat Microbot Medical's return on equity.Company Net Margins Return on Equity Return on Assets Bioventus-0.03% 23.04% 6.04% Microbot Medical N/A -76.27%-67.54% Do analysts prefer BVS or MBOT? Microbot Medical has a consensus price target of $12.00, indicating a potential upside of 196.30%. Given Microbot Medical's stronger consensus rating and higher probable upside, analysts plainly believe Microbot Medical is more favorable than Bioventus.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bioventus 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Microbot Medical 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media favor BVS or MBOT? In the previous week, Microbot Medical had 8 more articles in the media than Bioventus. MarketBeat recorded 9 mentions for Microbot Medical and 1 mentions for Bioventus. Microbot Medical's average media sentiment score of 0.79 beat Bioventus' score of 0.00 indicating that Microbot Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bioventus 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Microbot Medical 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, BVS or MBOT? Bioventus has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 1.22, meaning that its stock price is 22% more volatile than the S&P 500. Which has stronger valuation and earnings, BVS or MBOT? Microbot Medical has lower revenue, but higher earnings than Bioventus. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioventus$573.28M1.04-$33.54MN/AN/AMicrobot MedicalN/AN/A-$11.44M-$0.58-6.98 SummaryMicrobot Medical beats Bioventus on 8 of the 14 factors compared between the two stocks. Get Microbot Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBOT vs. The Competition Export to ExcelMetricMicrobot MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$177.17M$6.95B$5.87B$10.13BDividend YieldN/A1.21%5.68%4.60%P/E Ratio-6.9825.5274.5225.93Price / SalesN/A192.64517.44183.79Price / CashN/A22.1337.5660.44Price / Book23.825.0012.166.29Net Income-$11.44M$176.38M$3.28B$270.77M7 Day Performance10.66%1.00%0.87%3.88%1 Month Performance33.22%0.74%4.96%4.88%1 Year Performance309.09%10.34%60.75%26.01% Microbot Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBOTMicrobot Medical2.3591 of 5 stars$4.05+4.1%$12.00+196.3%+322.1%$177.17MN/A-6.9820News CoverageAnalyst ForecastBVSBioventus0.9983 of 5 stars$7.40+2.1%N/AN/A$611.83M$573.28M14.801,200AVNSAVANOS MEDICAL2.1375 of 5 stars$11.93+0.5%N/A-48.0%$554.05M$687.80M-1.192,227Positive NewsKIDSOrthoPediatrics4.3497 of 5 stars$21.36-0.4%$34.14+59.8%-37.8%$535.57M$204.73M-11.93200News CoveragePositive NewsZIMVZimVie1.263 of 5 stars$18.88-0.1%$17.75-6.0%+16.2%$532.43M$449.75M-26.971,770News CoveragePositive NewsTMCITreace Medical Concepts2.523 of 5 stars$7.34-0.8%$9.83+34.0%+42.7%$463.69M$209.36M-9.29250Positive NewsSMLRSemler Scientific2.9978 of 5 stars$29.64-3.2%$81.75+175.8%+18.7%$438.81M$56.29M3.52120CBLLCeriBell2.5129 of 5 stars$11.83-1.2%$32.14+171.7%N/A$433.73M$65.44M-3.96N/APositive NewsBFLYButterfly Network3.1579 of 5 stars$1.62-0.9%$3.00+85.8%-17.6%$405.30M$82.06M-5.77460DCTHDelcath Systems2.9841 of 5 stars$11.02+1.3%$24.50+122.3%+10.5%$385.49M$37.21M220.4060Positive NewsRXSTRxSight1.8773 of 5 stars$9.04-1.2%$10.00+10.6%-82.9%$369.88M$139.93M-11.30220Trending News Related Companies and Tools Related Companies Bioventus Alternatives AVANOS MEDICAL Alternatives OrthoPediatrics Alternatives ZimVie Alternatives Treace Medical Concepts Alternatives Semler Scientific Alternatives CeriBell Alternatives Butterfly Network Alternatives Delcath Systems Alternatives RxSight Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MBOT) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbot Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MBOT Stock Alerts